CVJan 30, 2023
Human Vision Based 3D Point Cloud Semantic Segmentation of Large-Scale Outdoor SceneSunghwan Yoo, Yeongjeong Jeong, Maryam Jameela et al.
This paper proposes EyeNet, a novel semantic segmentation network for point clouds that addresses the critical yet often overlooked parameter of coverage area size. Inspired by human peripheral vision, EyeNet overcomes the limitations of conventional networks by introducing a simple but efficient multi-contour input and a parallel processing network with connection blocks between parallel streams. The proposed approach effectively addresses the challenges of dense point clouds, as demonstrated by our ablation studies and state-of-the-art performance on Large-Scale Outdoor datasets.
CVMay 30, 2019
Prostate Cancer Detection using Deep Convolutional Neural NetworksSunghwan Yoo, Isha Gujrathi, Masoom A. Haider et al.
Prostate cancer is one of the most common forms of cancer and the third leading cause of cancer death in North America. As an integrated part of computer-aided detection (CAD) tools, diffusion-weighted magnetic resonance imaging (DWI) has been intensively studied for accurate detection of prostate cancer. With deep convolutional neural networks (CNNs) significant success in computer vision tasks such as object detection and segmentation, different CNNs architectures are increasingly investigated in medical imaging research community as promising solutions for designing more accurate CAD tools for cancer detection. In this work, we developed and implemented an automated CNNs-based pipeline for detection of clinically significant prostate cancer (PCa) for a given axial DWI image and for each patient. DWI images of 427 patients were used as the dataset, which contained 175 patients with PCa and 252 healthy patients. To measure the performance of the proposed pipeline, a test set of 108 (out of 427) patients were set aside and not used in the training phase. The proposed pipeline achieved area under the receiver operating characteristic curve (AUC) of 0.87 (95% Confidence Interval (CI): 0.84-0.90) and 0.84 (95% CI: 0.76-0.91) at slice level and patient level, respectively.